Gastric Juice Metabolic Reprogramming Along Correa’s Cascade: Discovery and Validation of a Metabolite Panel for Non-Invasive Early Detection of Gastric Cancer

Detection and endoscopic removal of EGC effectively reduced GC-caused mortality, yet no effective non-invasive screening approaches have been clinically used. Gastric juice integrates tissue- and gastric-microbiome-derived metabolites, making it a promising biofluid for screening EGC. To systematically profile metabolic reprogramming in gastric juice during gastric tumorigenesis, we carried out untargeted metabolic profiling in the discovery cohort enrolling patients at different stages along Correa’s cascade. We identified similar metabolic landscapes between HGD and EGC patients, which significantly differed from those of gastritis and intestinal metaplasia stages. These altered metabolites were subjected to origin analysis, revealing an association of both tumorigenesis-induced tissue metabolic reprogramming and gastric microbiome metabolic reprogramming, as supported by catalytic enzyme changes between tumor and adjacent normal tissues, and by bacteria-derived indole metabolites that correlated with altered gastric bacteria in GC patients. Least absolute shrinkage and selection operator (LASSO) was used for biomarker screening, and the selected metabolites were transferred into MRM-based targeted metabolic detection. A 4-metabolite panel-based diagnostic model was established in the discovery cohort and evaluated in an independent validation cohort, yielding an AUC of 0.90 (90.0% sensitivity, 79.0% specificity), with all three HGD and 20 of 23 EGC cases correctly classified. With the aid of endogastric capsules for non-invasive acquisition of gastric juice, our gastric juice metabolite-based test provides proof-of-concept evidence for its clinical utility in the early detection of GC and precancerous dysplasia.

Authors

Institutions

Publication Details

Journal
Biology
Published
2026-11-16
DOI
https://doi.org/10.3390/biology15222104
Primary Topic
Metabolomics and Mass Spectrometry Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Gastric Juice Metabolic Reprogramming Along Correa’s Cascade: Discovery and Validation of a Metabolite Panel for Non-Invasive Early Detection of Gastric Cancer

Jingwei Kang, 娄雅欣, Weiwei Fu, 崔荣丽 et al.
Biology
Metabolomics and Mass Spectrometry Studies
article

Gastric Juice Metabolic Reprogramming Along Correa’s Cascade: Discovery and Validation of a Metabolite Panel for Non-Invasive Early Detection of Gastric Cancer

Jingwei Kang, 娄雅欣, Weiwei Fu, 崔荣丽, Xin Liu, Xingting Guo, Yue Wen, Ying Xiong, Shigang Ding, Kangle Zhai, Guangmin Zuo, Jing Zhang
article en

Abstract

Detection and endoscopic removal of EGC effectively reduced GC-caused mortality, yet no effective non-invasive screening approaches have been clinically used. Gastric juice integrates tissue- and gastric-microbiome-derived metabolites, making it a promising biofluid for screening EGC. To systematically profile metabolic reprogramming in gastric juice during gastric tumorigenesis, we carried out untargeted metabolic profiling in the discovery cohort enrolling patients at different stages along Correa’s cascade. We identified similar metabolic landscapes between HGD and EGC patients, which significantly differed from those of gastritis and intestinal metaplasia stages. These altered metabolites were subjected to origin analysis, revealing an association of both tumorigenesis-induced tissue metabolic reprogramming and gastric microbiome metabolic reprogramming, as supported by catalytic enzyme changes between tumor and adjacent normal tissues, and by bacteria-derived indole metabolites that correlated with altered gastric bacteria in GC patients. Least absolute shrinkage and selection operator (LASSO) was used for biomarker screening, and the selected metabolites were transferred into MRM-based targeted metabolic detection. A 4-metabolite panel-based diagnostic model was established in the discovery cohort and evaluated in an independent validation cohort, yielding an AUC of 0.90 (90.0% sensitivity, 79.0% specificity), with all three HGD and 20 of 23 EGC cases correctly classified. With the aid of endogastric capsules for non-invasive acquisition of gastric juice, our gastric juice metabolite-based test provides proof-of-concept evidence for its clinical utility in the early detection of GC and precancerous dysplasia.

BiologyVol. 15(22)
Peking University (CN), Peking University Third Hospital (CN)
National Natural Science Foundation of China, Peking University Third Hospital, National Key Research and Development Program of China
Good health and well-being
Metabolomics and Mass Spectrometry Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon